Oscar Health (NYSE:OSCR) Stock Price Down 4.2% – Time to Sell?

Oscar Health, Inc. (NYSE:OSCR) shares traded down 4.2% during trading on Tuesday . The stock traded as low as $30.75 and last traded at $30.4610. 1,744,681 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 7,194,959 shares. The stock had previously closed at $31.81.

Analysts Set New Price Targets

A number of equities analysts have recently commented on OSCR shares. Piper Sandler reiterated an “overweight” rating and issued a $36.00 target price on shares of Oscar Health in a report on Tuesday, July 28th. Barclays lifted their price objective on shares of Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. The Goldman Sachs Group restated a “neutral” rating and issued a $30.00 target price on shares of Oscar Health in a report on Tuesday, August 11th. Wells Fargo & Company upped their price target on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Thursday, August 13th. Finally, Robert W. Baird set a $27.00 price objective on shares of Oscar Health in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $26.22.

Oscar Health Stock Down 4.0%

The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market cap of $9.43 billion, a PE ratio of 21.78, a price-to-earnings-growth ratio of 0.66 and a beta of 2.36. The business has a fifty day moving average of $30.08 and a 200-day moving average of $21.62.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.40 by $0.70. The company had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.Oscar Health’s quarterly revenue was up 70.4% on a year-over-year basis. During the same period last year, the business posted ($0.89) EPS. Equities research analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Mario Schlosser sold 880,000 shares of the stock in a transaction dated Tuesday, June 23rd. The shares were sold at an average price of $29.38, for a total transaction of $25,854,400.00. Following the transaction, the director directly owned 480,866 shares in the company, valued at $14,127,843.08. This represents a 64.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark T. Bertolini sold 624,244 shares of the firm’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $28.48, for a total transaction of $17,778,469.12. Following the transaction, the chief executive officer directly owned 7,751,570 shares in the company, valued at $220,764,713.60. This trade represents a 7.45% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 3,581,216 shares of company stock worth $103,424,940. Corporate insiders own 22.64% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

A number of large investors have recently bought and sold shares of OSCR. CoreCap Advisors LLC lifted its holdings in Oscar Health by 526.3% during the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock worth $34,000 after buying an additional 1,000 shares during the period. GAMMA Investing LLC raised its position in shares of Oscar Health by 32.9% in the 2nd quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after acquiring an additional 357 shares in the last quarter. Quarry LP raised its position in shares of Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares in the last quarter. FNY Investment Advisers LLC purchased a new stake in shares of Oscar Health during the 2nd quarter worth $57,000. Finally, Jones Financial Companies Lllp lifted its stake in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.